The study's authors urged physicians to use caution when prescribing these medications for "off-label indications." 

One key detail is that no stent thrombosis events were reported among the study's 201 participants. 

The study tracked nearly 500 patients for more than two decades. 

It’s likely that cardiologists will become quite familiar with the Digital Health Center of Excellence in the years ahead.

The study focused on more than 1,400 TAVR patients treated from August 2007 to June 2018. 

Recurrent coronary heart disease is also on the decline, according to a new analysis published in Circulation.

CVB asked leaders what they’re doing now to prepare for another COVID-19 wave.

NCI has formed a work group to review funding for TMIST, which is comparing digital breast tomosynthesis with older 2D mammo technology.